Literature DB >> 20417313

Inorganic nanomedicine--part 1.

Bhupinder S Sekhon1, Seema R Kamboj.   

Abstract

Inorganic nanomedicine refers to the use of inorganic or hybrid nanomaterials and nanosized objects to achieve innovative medical breakthroughs for drug and gene discovery and delivery, discovery of biomarkers, and molecular diagnostics. Potential uses for fluorescent quantum dots include cell labeling, biosensing, in vivo imaging, bimodal magnetic-luminescent imaging, and diagnostics. Biocompatible quantum dot conjugates have been used successfully for sentinel lymph node mapping, tumor targeting, tumor angiogenesis imaging, and metastatic cell tracking. Magnetic nanowires applications include biosensing and construction of nucleic acids sensors. Magnetic cell therapy is used for the repair of blood vessels. Magnetic nanoparticles (MNPs) are important for magnetic resonance imaging, drug delivery, cell labeling, and tracking. Superparamagnetic iron oxide nanoparticles are used for hyperthermic treatment of tumors. Multifunctional MNPs applications include drug and gene delivery, medical imaging, and targeted drug delivery. MNPs could have a vital role in developing techniques to simultaneously diagnose, monitor, and treat a wide range of common diseases and injuries. From the clinical editor: This review serves as an update about the current state of inorganic nanomedicine. The use of inorganic/hybrid nanomaterials and nanosized objects has already resulted in innovative medical breakthroughs for drug/gene discovery and delivery, discovery of biomarkers and molecular diagnostics, and is likely to remain one of the most prolific fields of nanomedicine. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20417313     DOI: 10.1016/j.nano.2010.04.004

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  11 in total

Review 1.  Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.

Authors:  Joel C Sunshine; Corey J Bishop; Jordan J Green
Journal:  Ther Deliv       Date:  2011-04

2.  Dendronized gold nanoparticles for siRNA delivery.

Authors:  Sung Tae Kim; Apiwat Chompoosor; Yi-Cheun Yeh; Sarit S Agasti; David J Solfiell; Vincent M Rotello
Journal:  Small       Date:  2012-08-08       Impact factor: 13.281

3.  Antimicrobial effects of silver zeolite, silver zirconium phosphate silicate and silver zirconium phosphate against oral microorganisms.

Authors:  Sirikamon Saengmee-Anupharb; Toemsak Srikhirin; Boonyanit Thaweboon; Sroisiri Thaweboon; Taweechai Amornsakchai; Surachai Dechkunakorn; Theeralaksna Suddhasthira
Journal:  Asian Pac J Trop Biomed       Date:  2013-01

4.  Doxorubicin-Wrapped Zinc Oxide Nanoclusters for the Therapy of Colorectal Adenocarcinoma.

Authors:  Sungyun Kim; Song Yi Lee; Hyun-Jong Cho
Journal:  Nanomaterials (Basel)       Date:  2017-10-28       Impact factor: 5.076

Review 5.  A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment.

Authors:  Joanna Jinling Lee; Latifah Saiful Yazan; Che Azurahanim Che Abdullah
Journal:  Int J Nanomedicine       Date:  2017-03-27

Review 6.  Anti-Methicillin-Resistant Staphylococcus aureus Nanoantibiotics.

Authors:  Raphaël Labruère; A J Sona; Edward Turos
Journal:  Front Pharmacol       Date:  2019-10-04       Impact factor: 5.810

Review 7.  Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.

Authors:  J A Smith; T Leonardi; B Huang; N Iraci; B Vega; S Pluchino
Journal:  Biogerontology       Date:  2014-06-28       Impact factor: 4.277

8.  Polymeric Nanocarriers with Luminescent Colloidal Nanoplatelets as Hydrophilic and Non-Toxic Two-Photon Bioimaging Agents.

Authors:  Katarzyna Celina Nawrot; Jan Kazimierz Zareba; Monika Toporkiewicz; Grzegorz Chodaczek; Dominika Wawrzynczyk; Julita Kulbacka; Urszula Bazylinska; Marcin Nyk
Journal:  Int J Nanomedicine       Date:  2021-05-27

9.  Enhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions.

Authors:  Xin Liu; Yang Xue; Tingting Ding; Jiao Sun
Journal:  Part Fibre Toxicol       Date:  2012-09-18       Impact factor: 9.400

10.  Delivery of cancer therapeutics using nanotechnology.

Authors:  Eun-Kyung Lim; Eunji Jang; Kwangyeol Lee; Seungjoo Haam; Yong-Min Huh
Journal:  Pharmaceutics       Date:  2013-05-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.